The Observation of the Efficacy of Shenmai Injection in Preventing and Treating Gastrointestinal Reactions during Chemotherapy of Hematological Malignancies
Abstract: 目的：观察参麦注射液防治恶性血液病化疗中胃肠道反应的疗效。方法：2016年1月~2017年12月，我院选择60例恶性血液病化疗病例，随机分成实验组及对照组2组，实验组化疗过程中应用参麦注射液，对照组不加用参麦注射液，观察化疗过程中胃肠道副反应。结论：应用参麦注射液(正大青春宝药业有限公司生产)静滴防治胃肠道副反应收到明显效果。 Aim: To observe the efficacy of Shenmai injection in preventing and treating gastrointestinal reactions during chemotherapy of hematological malignancies. Methods: From January 2016 to December 2017, our hospital selected 60 cases of chemotherapy for hematological malignancies and randomly divided them into two groups: an experimental group and a control group. The experimental group was treated with Shenmai injection during chemotherapy, and the control group did not use Shenmai injection. Gastrointestinal adverse effects are observed during chemotherapy. Conclusion: The application of Shenmai injection (produced by Zhengda Qingchunbao Pharmaceutical Co., Ltd.) intravenously in the prevention and treatment of gastrointestinal adverse effects has achieved significant results.
Click here to see the statistics on "Asian Case Reports in Oncology" .